HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Teresa Di Martino Selected Research

LNA-i-miR-221

9/2020Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS.
12/2019Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221.
6/2016Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates.
3/2016A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.
1/2014In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Teresa Di Martino Research Topics

Disease

37Neoplasms (Cancer)
06/2022 - 01/2007
22Multiple Myeloma
08/2021 - 10/2012
5Breast Neoplasms (Breast Cancer)
08/2019 - 04/2009
4Genomic Instability
01/2021 - 01/2019
3Hematologic Neoplasms (Hematological Malignancy)
03/2018 - 01/2016
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2022 - 01/2021
2Rare Diseases (Rare Disease)
01/2021 - 03/2020
2Fabry Disease (Fabry's Disease)
12/2017 - 12/2016
1Prostatic Neoplasms (Prostate Cancer)
06/2022
1Paraproteinemias (Monoclonal Gammopathy)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Idiopathic Pulmonary Fibrosis
11/2020
1Lung Neoplasms (Lung Cancer)
11/2020
1Melanoma (Melanoma, Malignant)
11/2020
1Drug-Related Side Effects and Adverse Reactions
03/2020
1Triple Negative Breast Neoplasms
02/2019
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Disease Progression
12/2017
1Inflammation (Inflammations)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Exanthema (Rash)
01/2016
1Neoplasm Metastasis (Metastasis)
09/2014
1Hypoxia (Hypoxemia)
05/2014
1Bone Diseases (Bone Disease)
07/2013
1Chromosome Aberrations (Chromosome Abnormalities)
06/2013
1Plasma Cell Leukemia
06/2013
1Colorectal Neoplasms (Colorectal Cancer)
11/2011
1Ovarian Neoplasms (Ovarian Cancer)
10/2009

Drug/Important Bio-Agent (IBA)

22MicroRNAs (MicroRNA)IBA
03/2022 - 10/2012
11Biomarkers (Surrogate Marker)IBA
03/2022 - 06/2013
6Pharmaceutical PreparationsIBA
01/2022 - 11/2011
6Biological ProductsIBA
01/2022 - 06/2013
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2012
5LNA-i-miR-221IBA
09/2020 - 01/2014
4EnzymesIBA
01/2022 - 01/2016
4locked nucleic acidIBA
06/2020 - 01/2014
3Proteins (Proteins, Gene)FDA Link
12/2017 - 02/2013
3mouse MIRN29 microRNAIBA
12/2013 - 10/2012
2AntigensIBA
06/2022 - 01/2021
2Monoclonal AntibodiesIBA
03/2021 - 01/2021
2Immune Checkpoint InhibitorsIBA
03/2021 - 11/2020
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2019 - 11/2011
2GalactosidasesIBA
12/2017 - 12/2016
2Untranslated RNA (Noncoding RNA)IBA
09/2016 - 06/2013
2Transcription Factors (Transcription Factor)IBA
08/2015 - 05/2014
2RNA (Ribonucleic Acid)IBA
09/2014 - 01/2014
2Nucleic AcidsIBA
01/2014 - 01/2014
2LipidsIBA
01/2014 - 01/2014
2PlatinumIBA
10/2009 - 04/2009
1CytokinesIBA
06/2022
1Glycoproteins (Glycoprotein)IBA
06/2022
1Lenalidomide (CC 5013)FDA Link
08/2021
1Chimeric Antigen ReceptorsIBA
03/2021
1AntibodiesIBA
03/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1OligonucleotidesIBA
12/2019
1B-Cell Maturation AntigenIBA
12/2019
1MethylcholanthreneIBA
08/2019
1Estrogens (Estrogen)FDA Link
02/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2019
1Estrogen ReceptorsIBA
02/2019
1IntegrinsIBA
02/2019
1Growth Factor ReceptorsIBA
02/2019
1GTP-Binding Proteins (G-Protein)IBA
02/2019
1Focal Adhesion Protein-Tyrosine KinasesIBA
02/2019
1TrabectedinIBA
01/2019
1DNA Ligase ATPIBA
01/2019
1taxaneIBA
01/2019
1Drug Receptors (Drug Receptor)IBA
12/2018
1CalreticulinIBA
12/2017
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
12/2017
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2016
1multidrug resistance-associated protein 1IBA
03/2016
1Melphalan (Alkeran)FDA LinkGeneric
03/2016
1Staphylococcal Protein A (Protein A)IBA
03/2016
1Large Neutral Amino Acid-Transporter 1IBA
03/2016
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1Cholecalciferol (Vitamin D3)FDA Link
01/2016
1ChitosanIBA
12/2015
1PhytochemicalsIBA
09/2014
1Transferrin (beta 2 Transferrin)IBA
01/2014
1MethyltransferasesIBA
12/2013
1Member 1 Subfamily G ATP Binding Cassette TransporterIBA
11/2011
1Irinotecan (Camptosar)FDA LinkGeneric
11/2011
1SuspensionsIBA
04/2009
1Cisplatin (Platino)FDA LinkGeneric
04/2009

Therapy/Procedure

10Therapeutics
01/2022 - 01/2007
6Immunotherapy
06/2022 - 12/2018
2Precision Medicine
01/2022 - 01/2022
1Prostatectomy (Retropubic Prostatectomy)
06/2022
1Enzyme Replacement Therapy
12/2017
1Drug Therapy (Chemotherapy)
09/2014